As an illustration, GSK3β has been reported to facilitate tumor progression in osteosarcoma and pancreatic cancer, while acting to suppress cancer development in colorectal cancer cells [13,26,27]. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.